Positive Results from Lupus Treatment Trial Boost Biogen’s Stock
Biogen Inc.'s stock surged 2% after announcing positive results from a late-stage trial of its lupus treatment, dapirolizumab pegol,...
late-stage trial
Sanofi’s Tolebrutinib Demonstrates Positive Results in Late-Stage MS Trial
In a groundbreaking development, Sanofi's experimental multiple sclerosis drug has demonstrated promising results in a late-stage trial, delaying disability...
Merck Halts Late-Stage Trial of Lung Cancer Treatment Due to Adverse Events
In a shocking turn of events, pharmaceutical giant Merck & Co. announced today that it's halting a late-stage trial...
Alnylam’s Heart Drug Vutrisiran Outperforms Pfizer’s Tafamidis in Late-Stage Trial
Alnylam Pharmaceuticals' stock soars after announcing vutrisiran, a heart drug competing with Pfizer's tafamidis, reduced the risk of death...
Moderna’s Stock Surges on Bird-Flu Vaccine Funding News
Moderna's stock rose 2.4% premarket as reports suggest a U.S. government deal for funding a late-stage trial of its...
Sanofi Ends Drug Program After Lung Cancer Trial Fails
Sanofi, the French pharmaceutical company, has announced that it will end the clinical-development program for its drug candidate, tusamitamab...
Argenx Stock Plummets After Disappointing Trial Results
Argenx stock plummeted by a third after the Amsterdam biotech announced that a late-stage trial for its drug, efgartigimod,...
Sanofi’s Sarclisa Drug Shows Promise in Late-Stage Trial
Sanofi's Sarclisa drug has shown positive results in a late-stage clinical trial for patients with newly diagnosed multiple myeloma....
BioXcel Therapeutics Shares Surge on Positive Audit of Trial Data
Shares of BioXcel Therapeutics surged 36% in premarket trading after the biopharmaceutical company announced that an independent audit of...